BMJ Supportive and Palliative Care, 2016, vol 6(3)
Two articles in this issue look at the net effects of drugs commonly used in palliative settings - pregablin for neuropathic pain and dexamethasone for anorexia. They both stem from an international pharmacovigilance programme established to better understand how medications affect hospice/palliative care patients. The aim in both cases is to add to the evidence base for the use of the drugs in these patients.
Full text available in BMJ Supportive and Palliative care - Pregablin for nueropathic pain
Full text available in BMJ Supportive and Palliative Care - Dexamethasone for anorexia
Available in print in Arthur Rank Hospice Library, Cambridge